MetLife Investment Management, LLCMetLife Investment Management, LLC

Institutional investor · Portfolio as of Q1 2025

SEC EDGAR SourceSEC Filings

Top Holdings2,781 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

APPLE INC

4.5M$997.5M5.4%

MICROSOFT CORP

2.2M$837.7M4.5%

NVIDIA CORP

7.3M$789.9M4.3%

AMAZON.COM INC

2.8M$539M2.9%

META PLATFORMS INC-CLASS A

646,828$372.8M2.0%
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

646,800$361.8M2.0%

ALPHABET INC-CL A

1.8M$271.7M1.5%

BERKSHIRE HATHAWAY INC-CL B

476,045$253.5M1.4%

BROADCOM INC

1.4M$235.8M1.3%

ALPHABET INC-CL C

1.4M$223.3M1.2%

TESLA INC

847,530$219.6M1.2%

ELI LILLY & CO

239,748$198M1.1%

VISA INC-CLASS A SHARES

522,779$183.2M1.0%

JPMORGAN CHASE & CO

726,497$178.2M1.0%
2.2M$172.7M0.9%

MASTERCARD INC - A

247,062$135.4M0.7%

EXXON MOBIL CORP

1.1M$134.6M0.7%

COSTCO WHOLESALE CORP

134,595$127.3M0.7%

UNITEDHEALTH GROUP INC

241,748$126.6M0.7%

NETFLIX INC

129,741$121M0.7%
$18.5B
AUM
2,781
Positions
Q1 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
+8%Q4'23$13.9B+7%Q1'24$14.9B+13%Q2'24$16.8B+4%Q3'24$17.4B+6%Q4'24$18.4B+1%Q1'25$18.5B
Activity profile
$ moved · Q1'25
New2%Increased39%Decreased59%Exited1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.9 years
<1Q1%1-4Q5%1-2Y5%2Y+89%

MetLife Investment Management, LLC manages $18.5B across 2781 positions as of Q1 2025. Top holdings: AAPL (5.4%), MSFT (4.5%), NVDA (4.3%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2/5.0.

Q1 2025 Summary

Active quarter - 47 new positions, 76 exits, 469 increased. No standout high-conviction moves this quarter. Portfolio: $18.5B across 2781 positions.

Top holdings by portfolio weight

Total AUM$19B
AAPL5.38%
MSFT4.52%
NVDA4.26%
AMZN2.91%
META2.01%
SPY1.95%
GOOGL1.47%
BRK/B1.37%
AVGO1.27%
GOOG1.21%
Other1.19%

Portfolio allocation by GICS sector

Sectors11
Technology25.99%
Financial Services14.11%
Healthcare11.01%
Consumer Cyclical10.45%
Industrials9.22%
Communication Services7.28%
Consumer Defensive5.33%
Unknown4.81%
Real Estate3.74%
Energy3.53%
Other4.52%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Financial Services, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record62
Conviction38
Concentration41
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AGNCAGNCAGNC INVESTMENT CORP
Q3 2024 Q2 2026+6,265 shares+$85,197
6Q
ASPIASPIASP ISOTOPES INC
Q1 2025 Q2 2026+43,739 shares+$315,976
6Q
QBTSQBTSD-WAVE QUANTUM INC
Q1 2025 Q2 2026+155,929 shares+$4.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used